Zhaoke

Zhaoke Ophthalmology Limited engages in the development, manufacturing, and marketing of ophthalmic drugs. Its diversified product portfolio includes small molecules and biologics, as well as new drugs and generics, covering various ophthalmic indications such as dry eye, glaucoma, wet age-related macular degeneration, diabetic retinopathy, corneal injury, and inflammatory diseases. With deep domain expertise, Zhaoke has built a comprehensive pipeline of 25 drug candidates through self-development or licensing, addressing most major ophthalmic conditions affecting both the anterior and posterior segments of the eye.